Stimulation of collateral artery growth: a potential treatment for peripheral artery disease

References

• Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436–1442 (1997).
   PubMed Web of Science ®Google Scholar
• Ouriel K Peripheral arterial disease. Lancet 358, 1257–1264 (2001).
   PubMed Web of Science ®Google Scholar
• Criqui MH, Langer RD, Fronek A et al Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl Med 326,381–386 (1992).
   PubMed Web of Science ®Google Scholar
• •Demonstrates the enormous impact of peripheral artery disease (PAD) on life expectancy.
   Google Scholar
• Hiatt WR. Pharmacologic therapy for peripheral arterial disease and claudication. Vasc. &lg. 36,1283–1291 (2002).
   Google Scholar
• Dean SM. Pharmacologic treatment for intermittent claudication. Vasc. Med.7, 301–309 (2002).
   Google Scholar
• Molloy KJ, Nasim A, London NJ et al Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. Endovasc. Ther. 10, 298-303 (2003).
   Google Scholar
• Watson HR, Belcher G, Horrocks M. Reintervention as a clinical trial end point after peripheral arterial bypass surgery. Br J. Sing. 88,1376–1381 (2001).
   Google Scholar
• Matsi PJ, Manninen HI, Soder HK, Mustonen P, Kouri J. Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin. Radial. 50,237–244 (1995).
   Google Scholar
• Lower R Early science in Oxford. In: Oxfird. Oxford University Press, Oxford, UK (1932).
   Google Scholar
• Fulton WME The Coronary Arteries. Charles C Thomas Publishers, IL, USA (1965).
   Google Scholar
• ••Impressive monograph in which the authorunequivocally demonstrates the presence of pre-existing collateral anastomoses in the healthy human heart and the recruitment of these anastomoses in atherosclerotic disease.
   Google Scholar
• Schaper W. On arteriogenesis — a reply. Basic Res. Cardial 98,183-184 (2003).
   PubMed Web of Science ®Google Scholar
• Risau W Mechanisms of angiogenesis. Nature 386,671–674 (1997).
   PubMed Web of Science ®Google Scholar
• Buschmann I, Schaper W Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physid Sci. 14,121–125. (1999).
   Google Scholar
• van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc. Res. 49,543–553. (2001).
   Google Scholar
• Helisch A, Schaper W Angiogenesis and arteriogenesis — not yet for prescription. Z Kardiol. 89,239–244 (2000).
   Google Scholar
• Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am. Coll Cordial. 28,1652-1660 (1996).
   Google Scholar
• Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc. Nad Acta Sci. USA 91,4678–4682. (1994).
   Google Scholar
• Randolph GJ, Furie MB. A soluble gradient of endogenous monocyte c.hemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol. 155,3610–3618 (1995).
   Google Scholar
• Scholz D, Ito W Fleming I et al Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virrhows Arch. 436,257–270 (2000).
   PubMed Web of Science ®Google Scholar
• Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.j Clin. Invest. 101,40–50. (1998).
   Google Scholar
• •One of the earliest publications in which arteriogenesis is described as a separate process to angiogenesis.
   Google Scholar
• Cai WJ, Koltai S, Kocsis E et al. Remodeling of the adventitia during coronary arteriogenesis. Am. J. PhysioL Heart Circ. Physiol. 284, H31—H40 (2003).
   Web of Science ®Google Scholar
• Malik N, Greenfield BW, Wahl AF, Kiener PA. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156,3952–3960 (1996).
   Google Scholar
• Hoefer IE, van Royen N, Rectenwald JE et al Direct evidence for tumor necrosis factor-a signaling in arteriogenesis. Circulation 105, 1639–1641 (2002).
   PubMed Web of Science ®Google Scholar
• Scholz D, Ziegelhoeffer T, Helisch A et al Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J MoL Cell Cordial. 34, 775–787 (2002).
   PubMed Web of Science ®Google Scholar
• Hoefer IE, Voskuil M, van Royen N. Arteriogenesis in mice. In: The Physiological Genomics of the Critically Ill Mouse. Ince C (Ed.), Kluwer Academic Publishers, MA, USA (2003).
   Google Scholar
• Van Royen N, Voskuil M, Hoefer I et al. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization. Circulation 109(13), 1647–1652 (2004).
   PubMed Web of Science ®Google Scholar
• Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc. Res. 49, 609–617 (2001).
   Google Scholar
• Deindl E, Buschmann I, Hoefer IE et al Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89, 779–786 (2001).
   PubMed Web of Science ®Google Scholar
• Pu LQ, Jackson S, Lachapelle KJ et al A persistent hindlimb ischemia model in the rabbit. J. Invest. Surg. 7, 49–60 (1994).
   PubMedGoogle Scholar
• Buschmann IR, Voskuil M, van Royen N et al. Invasive and noninvasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease. Atherosclerosis 167,33-43 (2003).
   Google Scholar
• Voskuil M, van Royen N, Hoefer IE et al Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am. J. Physid Heart Circ. Physiol. 284, H1422—H1428 (2003).
   Web of Science ®Google Scholar
• Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80,829–837 (1997).
   Google Scholar
• •First report on the therapeutic modulation of collateral artery growth via attraction of monocytes to sites of vascular proliferation via exogenous application of monocyte chemoattractant protein-1.
   Google Scholar
• van Royen N, Hoefer I, Buschmann I et al Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe-hyperlipidemic rabbits. Cardiovasc Res. 57, 178–185 (2003).
   PubMed Web of Science ®Google Scholar
• van Royen N, Hoefer I, Bottinger M et al. Local monocyte c. hemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD1 lb expression, neointimal formation and plaque progression. Circ. Res. 92,218–225 (2003).
   PubMed Web of Science ®Google Scholar
• Buschmann IR, Hoefer IE, van Royen N et al. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159,343-356 (2001).
   Google Scholar
• Flad HD, Grage-Griebenow E, Scheuerer B et al. The role of cytokines in monocyte apoptosis. Res. Immunol. 149,733-736 (1998).
   Google Scholar
• van Royen N, Hoefer I, Buschmann I et al Exogenous application of transforming growth factor-131 stimulates arteriogenesis in the peripheral circulation. Faseb J. 16, 432–434. (2002).
   PubMed Web of Science ®Google Scholar
• Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial transforming growth factor-131 transcription and production. Modulation by potassium channel blockade./ Clin. Invest. 95, 1363-1369
   Google Scholar
• Wahl SM, McCartney-Francis N, Allen JB, Dougherty EB, Dougherty SE Macrophage production of TGF-13 and regulation by TGF-13. Ann. 1VY Acad Sci. 593,188-196 (1990).
   Google Scholar
• Boengler K, Pipp F, Fernandez B, Ziegelhoeffer T, Schaper W Deindl E. Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (CARP). Cardiovasc. Res. 59,573–581 (2003).
   Google Scholar
• Epstein SE, Fuchs S, Thou YF, Baffour R,
   Google Scholar
• Kornowski R Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc. Res. 49,532–542 (2001).
   PubMed Web of Science ®Google Scholar
• Deindl E, Hoefer IE, Fernandez B et al
   Google Scholar
• Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Circ Res. 92,561–568 (2003).
   PubMed Web of Science ®Google Scholar
• Doukas J, Blease K, Craig D et al Delivery of
   Google Scholar
• FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. MoL Ther. 5,517–527 (2002).
   PubMed Web of Science ®Google Scholar
• Ueno H, Li JJ, Masuda S, Qi Z, Yamamoto H, Takeshita A. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler Thromb. Vasa Biol. 17, 2453–2460 (1997).
   Google Scholar
• Yang HT, Deschenes MR, Ogilvie RW, Terjung RE. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79,62–69 (1996).
   Google Scholar
• Rissanen TT, Markkanen JE, Arve K et al Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischaemia model. Faseb J. 17,100–102 (2003).
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N EngL J. Med 285, 1182-1186 (1971).
   Google Scholar
• Hershey JC, Baskin EP, Corcoran HA et al Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 18,142–149 (2003).
   PubMed Web of Science ®Google Scholar
• Crottogini A, Meckert PC, Vera Janavel G et al. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum. Gene Then 14, 1307–1318 (2003).
   Google Scholar
• Heil M, Clauss M, Suzuki K et al Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur. J. Cell. Biol. 79, 850–857 (2000).
   PubMed Web of Science ®Google Scholar
• Pipp F, Heil M, Issbrucker K et al. VEGFR-1-selective VEGF homologue P1GF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92, 378–385 (2003).
   PubMed Web of Science ®Google Scholar
• Asahara T, Masuda H, Takahashi T et al Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221–228 (1999).
   PubMed Web of Science ®Google Scholar
• Kburana R, Simons M. Endothelial progenitor cells: precursors for angiogenesis. Semin. Thorac. Cardiovasc. Surg. 15,250–258 (2003).
   PubMedGoogle Scholar
• Kamihata H, Matsubara H, Nishiue T et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler. Thromb. Vasa Biol. 22, 1804–1810 (2002).
   PubMed Web of Science ®Google Scholar
• Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration and body distribution. Circulation 108, 863–868 (2003).
   PubMed Web of Science ®Google Scholar
• Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation 104, 1046–1052 (2001).
   PubMed Web of Science ®Google Scholar
• Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 193,1094–1100 (1976).
   Google Scholar
• Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164–1169 (2003).
   Google Scholar
• •Critically evaluates the endothelial progenitor cell theory and shows that these cells might well be derived from monocytes.
   Google Scholar
• Ziegelhoeffer T, Scholz D, Friedrich C et al. Inhibition of collateral artery growth by mibefradil: possible role of volume-regulated chloride channels. Endothelium 10,237-246 (2003).
   Google Scholar
• Isner JM, Pieczek A, Schainfeld R et al Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 in patient with ischemic limb. Lancet 348, 370–374 (1996).
   PubMed Web of Science ®Google Scholar
• ••Reports the first use of vascularendothelial growth factor (VEGF) in patients, as a potential new treatment for peripheral artery disease.
   Google Scholar
• Baumgartner I, Pieczek A, Manor 0 et al Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia. Circulation 97, 1114–1123 (1998).
   PubMed Web of Science ®Google Scholar
• Mohler ER 3rd, Rajagopalan S, Olin JW et al. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischaemia: safety results from a Phase I trial. Vasc. Med. 8,9-13 (2003).
   Google Scholar
• Henry TD, Annex BH, McKendall GR et al. The VIVA Trial: Vascular endothelial growth factor in Ischaemia for Vascular Angiogenesis. Circulation 107,1359-1365 (2003).
   Google Scholar
• Rajagopalan S, Mohler ER 3rd, Lederman RJ et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a Phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108,1933–1938 (2003).
   Google Scholar
• ••Describes the first large randomizedcontrolled trial on the use of VEGF in patients with PAD. No significant change in peak walking exercise time was found.
   Google Scholar
• Lazarous DF, Unger EF, Epstein SE et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a Phase I trial. J. Am. Coll. Cardiol. 36, 1239–1244 (2000).
   PubMed Web of Science ®Google Scholar
• Cooper LT Jr, Hiatt WR, Creager MA et al Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication. Vasc. Med. 6, 235–239 (2001).
   PubMed Web of Science ®Google Scholar
• Comerota AJ, Throm RC, Miller KA et al Naked plasmid DNA encoding fibroblast growth factor Type 1 for the treatment of end stage unreconstructible lower extremity ischemia: preliminary results of a Phase I trial. J. Vasc. Surg. 35,930–936 (2002).
   PubMed Web of Science ®Google Scholar
• Lederman RJ, Mendelsohn FO, Anderson RD et al Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 359, 2053–2058 (2002).
   Google Scholar
• Seiler C, Pohl T, Wustmann K et al Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104,2012–2017 (2001).
   PubMed Web of Science ®Google Scholar
• ••Shows for the first time the efficacy ofmodulation of collateral artery growth in the clinical setting.
   Google Scholar
• van Royen N, Piek JJ, Legemate DA et al Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. Vasc. Med 8,191–196 (2003).
   PubMed Web of Science ®Google Scholar
• Heil M, Ziegelhoeffer T, Mees B, Schaper W A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ. Res. 94,573–574 (2004).
   Google Scholar
• Ziegelhoeffer T, Fernandez B, Kostin S et al Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94,230–238 (2004).
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T et al Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360,427–435 (2002).
   Google Scholar
• Simons M, Bonow RO, Chronos NA et al Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102, E73—E86 (2000).
   PubMed Web of Science ®Google Scholar